OCT 05, 2016 10:00 AM PDT

When Good Biomarkers Go Bad: Effectively Utilizing Procalcitonin (PCT) for Sepsis Management to Demonstrate the Value of the Lab

SPONSORED BY: LabLeaders, LabLeaders
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College
    Biography
      Dr. Hayden is a board certified clinical chemist with a special interest in the development and implementation of new diagnostics, in particular mass spectrometry-based assays for small molecule analysis.

      Dr. Hayden obtained a PhD in chemistry from Carnegie Mellon University and went on to conduct postdoctoral research at the Massachusetts Institute of Technology. He then completed a two-year clinical chemistry fellowship at the University of Washington, where he trained under the mentorship of Dr. Geoffrey Baird and Dr. Andrew Hoofnagle. He currently is an assistant professor at Weill Cornell Medical College where he serves as Director of the Toxicology and Therapeutic Drug Monitoring laboratory and Assistant Director of the Central Laboratory at Weill Cornell/New York Presbyterian Hospital.

    Abstract:
    DATE:  October 5, 2016
    TIME:  10:00am PT, 1:00pm ET

    Sepsis, a host-mediated response to a systemic infection, is a leading cause of mortality worldwide (1).  Early recognition of infection and initiation of effective therapy is essential to reducing mortality from sepsis; every hour that effective therapy is delayed causes an 8% increase in mortality (2).  Sepsis management is now a Centers for Medicare & Medicaid Services (CMS) core measure, and includes a number of required laboratory measurements.  One of the most effective biomarkers for sepsis is procalcitonin (PCT) which has demonstrated excellent sensitivity to sepsis.  This biomarker puts laboratory leaders in a unique position to greatly impact sepsis protocol by providing a solution that can aid in early identification of systemic bacterial infection, assess mortality risk and guide antimicrobial effectiveness (3). Unfortunately, the utility of PCT has been limited in clinical practice by its availability and turnaround time (TAT).  This talk will focus on the role PCT can play in recognizing and managing sepsis as well as the relevant operational features (TAT, availability) and institutional buy-in necessary to achieve maximum utility from this marker of sepsis and the unique opportunity it presents for lab leaders to bring more value to the laboratory.

    Learning Objectives:
    At the conclusion of this talk, attendees should be able to…
    1. Summarize the requirements and implications of the new sepsis CMS core measure
    2. Explain the role of PCT in identifying and managing sepsis
    3. Decide on the required clinical performance necessary for PCT to be impactful, especially with regards to turnaround time (TAT) and test availability
    4. Understand how lab leaders should position PCT with key stakeholders to maximize adoption and clinical utility.
    Works Cited:
    1. Singer M, Deutschman CS, Seymour C, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 315(8) (2016) 801-810.
    2. Kumar A, Roberts D, Wood K, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34 (2006) 1589–1596.
    3. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin Algorithms for Antibiotic Therapy Decisions: A Systematic Review of Randomized Controlled Trials and Recommendations for Clinical Algorithms. Arch Intern Med. 171(15) (2011) 1322-1331.
    Roche Diagnostics is proud to announce the recent FDA Clearance for the Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing solution for people with severe sepsis or septic shock. With this clearance, Roche is the first IVD company in the U.S to join the fight against sepsis with a fully integrated solution, giving clinicians greater clarity when it matters most. The Elecsys BRAHMS PCT assay can help rapidly confirm bacterial infection in minutes, accurately assess mortality risk and assist clinicians in safely de-escalating antiobiotic treatment and provides a powerful opportunity for lab leaders to demonstrate the value of the lab throughout the continuum of care.

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUL 30, 2019 10:00 AM PDT
    C.E. CREDITS
    JUL 30, 2019 10:00 AM PDT
    DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    Loading Comments...
    Show Resources